RCF Q2 FY27: Consol PAT up 24% YoY to ₹131 Cr on chemicals surge, fertiliser profit dips
PAT +24.29% YoY · revenue -4.33% · margins expanding
₹5,063.19 Cr
-4.33% YoY
₹130.94 Cr
+24.29% YoY
2.57%
+0.6pp YoY
₹2.37
RCF's consolidated PAT for Q2 FY27 (quarter ended 30 September 2026) came in at ₹130.94 Cr, up 24.3% YoY from ₹105.35 Cr, even as consolidated revenue slipped 4.3% YoY to ₹5,063.19 Cr from ₹5,292.58 Cr. Standalone PAT was near-identical at ₹131.45 Cr (EPS ₹2.38 standalone / ₹2.37 consolidated), with the ₹0.51 Cr gap arising from the company's share of a joint-venture loss — the two bases tell the same story this quarter. Sequentially, revenue jumped 41.2% and PAT 78.1% over Q1 FY27 (₹3,585.71 Cr / ₹73.53 Cr), but that swing is a Kharif-season seasonality artifact for a urea-heavy fertiliser business rather than a sign of accelerating momentum — the YoY comparison is the one that matters here.
Q2 FY-2027 vs prior quarters
Net profit margin expanded to 2.59% from 1.99% YoY and operating margin to 5.97% from 4.05%, but the margin expansion masks a split performance across segments. The core Fertiliser segment — about 78% of revenue — saw its profit fall 21.7% YoY to ₹84.94 Cr from ₹108.49 Cr, even as fertiliser revenue grew 33.9% YoY to ₹3,945.22 Cr, because the Department of Fertilizers' revision of the energy norm for RCF's Thal unit (to 5.984 Gcal/MT from 6.200 Gcal/MT, retrospective to April 2025) cut subsidy income by a further ₹60.17 Cr this quarter — on top of ₹132.52 Cr booked for FY26 in Q1 FY27 and ₹39.02 Cr recognised for Q1 FY27 itself, taking the cumulative FY27 impact to ₹231.71 Cr. The quarter's profit growth instead came from Industrial Chemicals, whose segment profit nearly quadrupled to ₹144.93 Cr from ₹41.77 Cr YoY (+247%) on revenue growth of just 54.5% (₹505.93 Cr from ₹327.49 Cr) — implied segment margin expanded from roughly 12.8% to 28.6%, and its profit now exceeds Fertiliser's despite a fraction of the revenue. Trading, the third segment, collapsed 69.8% YoY to ₹608.40 Cr in revenue with profit falling to ₹10.57 Cr from ₹47.51 Cr, explaining most of the topline decline.
The stock went into the print at ₹108.1, up 2.9% over the past month of trading.
For context: this is the second-highest quarterly PAT of the last 6 quarters.
What the summary numbers don't show
No exceptional items in either this quarter or the year-ago quarter
We found no specific analyst or brokerage consensus estimates for RCF's Q2 FY27 PAT in public previews, so the print cannot be graded against the Street; the company also carries no formal prior guidance or concall outlook on record, so it cannot be graded against management's own targets either. During the quarter, RCF awarded a ₹797 Cr ammonia-plant revamp order to L&T (25 September 2026), shareholders approved a ₹1,500 Cr further public offer (26 September 2026), and the company onboarded Raju & Prasad as new statutory auditors — capacity and capital-raising moves that sit alongside, rather than explain, this quarter's P&L. No management press release accompanying this filing was available to cross-check against the reported numbers.
W1
Whether the Industrial Chemicals segment can sustain its ~28.6% margin (vs ~12.8% a year ago) that drove this quarter's profit growth
W2
Resolution of the ₹203.41 Cr cumulative GAIL gas-pooling dispute after DoF's October 2026 rejection of RCF's representation
W3
Trading segment revenue trajectory after the 69.8% YoY decline to ₹608.40 Cr
Navigating Energy Norms: Can Chemicals Offset Margin Headwinds?
RCF enters Q2 after a strong Q1 rebound, but faces structural headwinds from tightened energy norms and soft fertilizer markets. Watch how margin pressure flows through and whether capex plans signal confidence in a turnaround.
The Setup: Q1 Bounce Meets Structural Headwinds
RCF's Q1 FY27 print (ended June 2026) surprised to the upside—consolidated PAT surged 35% YoY to ₹73.53 Cr on revenue growth of 6.4% to ₹3,585.71 Cr, driven by a chemicals segment rally. However, the fertilizer division remained underwater, and the company flagged a ₹171.54 Cr structural hit from revised energy-efficiency norms announced by the Department of Fertilizers in July. Q2 will test whether chemicals strength can absorb that margin erosion and deliver a print that holds Q1's trajectory or moderates into what Street analysts have priced as a recovery stock—still 55% below the average analyst target of ₹159.2.
~₹3,600–3,700 Cr
on-plan trajectory from Q1's ₹3,585.71 Cr; seasonal normalize post-monsoon
~₹70–85 Cr
moderating from Q1's 35% YoY bounce; energy norm headwinds and fertilizer drag offset chemicals strength
Energy norms pass-through
₹171.54 Cr cumulative impact begins to flow; degree of realization will set tone for H2
A strong Q2 would show chemicals segment maintaining momentum (high-value specialty and agrochemicals output), PAT above ₹80 Cr despite energy norm drag, and management confident enough to proceed with the ₹1,100 Cr NCD raise. A weak Q2 would signal energy norm pass-through faster than expected, fertilizer losses widening, and guidance revision—causing Street to reset its 2027 EPS assumptions downward.
On Track for Guidance?
RCF has not published explicit FY27 guidance, but Q1's 35% PAT growth implied confidence. However, that rebound came off a weak FY26 base (energy crisis, softer ag prices) and chemicals benefited from a margin spike that may not sustain. The energy norm reset is permanent—a legacy urea plant efficiency loss that cannot be engineered away in months. Q2 will be the first print to truly absorb this cost, making it a key data point to judge whether management's capex strategy (₹797 Cr L&T ammonia revamp, targeting 0.40 Gcal/MT energy savings by July 2027) is credible or late.
Since Last Quarter: Big Capex, New Venture
1 · ₹797 Cr L&T Ammonia Plant Revamp (Sept 25)
Board approved the capex order for Thal unit energy modernisation. Supplier: M/s Larsen & Toubro. Target energy saving: 0.40 Gcal/MT of ammonia at existing production levels. Completion July 2027. This is RCF's answer to the ₹171.54 Cr energy norm hit; marks a 3-year journey to cost recovery.
2 · RCF-GAIL Joint Venture MoU (July 29)
Entered MoU with GAIL (India) for a new gas-based urea plant in Vidarbha, Maharashtra. Capacity: 1.27 MTPA. This is transformational—gas-based plants have superior energy profiles and work around the norms reset. Timelines and capex details to follow; watch for formal pact signing post-result.
3 · ₹1,100 Cr NCD Issuance Plan (Aug 13)
Board approved plan to raise ₹1,100 Cr via non-convertible debentures. No timing disclosed. This signals medium-term capex funding strategy (both L&T revamp and JV). Market execution will depend on Q2 sentiment and credit rating stability.
4 · Ownership Shift (FII decline to 2.43%)
FII holding fell 17 bps QoQ to 2.43% (Q1 FY27 vs Q4 FY26). DII flat at 0.31%. Promoter stable at 75%. Signals light FII appetite in face of energy norm reset; watch for stabilization post-Q2 results if management reaffirms JV timeline.
5 · Board & Compliance (Routine)
New independent director appointed (Aug 31). Statutory auditors refreshed for FY27. NSE/BSE levied ₹15.78 Lakh combined fine for SEBI LODR non-compliance (Q1 filing delays). Trading window closed from Oct 1 for Q2 result. All routine.
What to Watch on Result Day (Nov 12)
1. Margin bridge: How much of the energy norm hit flowed through Q2 EBITDA? If fertilizer EBITDA margin has collapsed 200+ bps QoQ, energy cost is the culprit. 2. Chemicals momentum: Did specialty/agrochemical volumes hold? Any pricing power lost? 3. Capex & NCD timing: Any update on L&T revamp start date and NCD issuance window? 4. JV progress: Signed agreement with GAIL yet, or still MoU stage? Project timeline firmed? 5. FY27 guidance: Likely muted (given energy norm permanence), but watch for any EPS guidance floor or H2 outlook statement. 6. Dividend: Q1 saw no interim dividend; no payout guidance yet. Will management maintain capital discipline or signal recovery confidence via dividend?
RCF's Q2 is a litmus test for margin resilience and management credibility on capex. Q1's 35% PAT bounce was a relief, but it came off a weak base and from one-off chemicals outperformance. The energy norm reset is structural and permanent—Q2 will show the true cost. If chemicals hold, PAT can stabilize in the ₹75–85 Cr range; if chemicals roll over or energy costs exceed guidance, Street will reprice lower. The real long-term story is the RCF-GAIL JV and L&T capex, which could reframe the margin outlook by FY28—but those are 18+ months away. For now, the question is Q2: Can the company absorb ₹171.54 Cr of energy norm headwinds and still grow? Watch EBITDA margin, chemicals segment, and any corporate action timing for clues on management confidence.